Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
19851.9k citationsMichael J. Hope, Pieter R. Cullis et al.Biochimica et Biophysica Acta (BBA) - Biomembranesprofile →
Vesicles of variable sizes produced by a rapid extrusion procedure
19861.5k citationsMichael J. Hope, Pieter R. Cullis et al.Biochimica et Biophysica Acta (BBA) - Biomembranesprofile →
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
20191.2k citationsAkin Akinc, Martin A. Maier et al.Nature Nanotechnologyprofile →
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
2012973 citationsMuthusamy Jayaraman, Steven M. Ansell et al.profile →
Lipid Nanoparticle Systems for Enabling Gene Therapies
2017842 citationsPieter R. Cullis, Michael J. HopeMolecular Therapyprofile →
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
2015688 citationsNorbert Pardi, Steven Tuyishime et al.Journal of Controlled Releaseprofile →
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
2015401 citationsBarbara L. Mui, Michael J. Hope et al.Molecular Therapyprofile →
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017267 citationsNorbert Pardi, Anthony Secreto et al.Nature Communicationsprofile →
2018201 citationsNorbert Pardi, Kaela Parkhouse et al.Nature Communicationsprofile →
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018154 citationsHamideh Parhiz, Vladimir V. Shuvaev et al.Journal of Controlled Releaseprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Michael J. Hope
Since
Specialization
Citations
This map shows the geographic impact of Michael J. Hope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Hope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Hope more than expected).
This network shows the impact of papers produced by Michael J. Hope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Hope. The network helps show where Michael J. Hope may publish in the future.
Co-authorship network of co-authors of Michael J. Hope
This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Hope.
A scholar is included among the top collaborators of Michael J. Hope based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Michael J. Hope. Michael J. Hope is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Akinc, Akin, Martin A. Maier, Muthiah Manoharan, et al.. (2019). The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nature Nanotechnology. 14(12). 1084–1087.1160 indexed citations breakdown →
Parhiz, Hamideh, Vladimir V. Shuvaev, Norbert Pardi, et al.. (2018). PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. Journal of Controlled Release. 291. 106–115.154 indexed citations breakdown →
Cullis, Pieter R. & Michael J. Hope. (2017). Lipid Nanoparticle Systems for Enabling Gene Therapies. Molecular Therapy. 25(7). 1467–1475.842 indexed citations breakdown →
6.
Pardi, Norbert, Anthony Secreto, Xiaochuan Shan, et al.. (2017). Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nature Communications. 8(1). 14630–14630.267 indexed citations breakdown →
7.
Mui, Barbara L., Robert D. Leone, Kim F. Wong, et al.. (2005). Encapsulation of crystalline topotecan in sphingosomes: a formulation suitable for clinical development. Cancer Research. 65. 326–327.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.